Fused ring pyrimidine compound salt and crystal form, and preparation method and application thereof
A technology for fused-ring pyrimidines and compounds, which is applied to salts, crystal forms of fused-ring pyrimidine compounds and their preparation and application fields, can solve the problems of low dissolution rate, easy moisture absorption, low absorption rate and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0117] Embodiment 1 The preparation of the fumarate of the condensed ring pyrimidine compound shown in formula 2
[0118] Weigh the compound N-[7-(4-fluoro-2-methoxyphenyl)-6-methylthieno[3,2-d]pyrimidin-2-yl]-1-(piperidine-4- base)-1H-pyrazol-4-amine (synthesized according to Patent CN106366093A Example 31) 100mg (0.228mmol, 1eq) into the vial, add 10mL 88% acetone-water solution, add the vial at about 50°C and stir until dissolved clear. 1.1mL ethanol solution (0.275mmol, 1.2eq) of fumaric acid with a concentration of 0.25mol / L was slowly added dropwise to the free base solution of fused ring pyrimidines, and stirred and reacted at 50°C for 1 hour, and then the solution was Slowly cool down to room temperature at a rate of 5°C / h, collect the solid and dry under vacuum at 40°C overnight.
[0119] 1 H-NMR (400MHz, DMSO-d 6 )δ:9.45(s,1H),8.94(s,1H),7.75(s,1H),7.78-7.33(m,2H),7.15(d,J=6.4Hz,1H),6.99(dd,J =7.6Hz,J=7.2Hz,1H),6.42(s,1H),4.10(m,1H),3.73(s,3H),3.17(d,J=12.4Hz,2H...
Embodiment 2
[0120] Embodiment 2 Preparation of the adipate salt of the fused ring pyrimidine compound shown in formula 3
[0121] Referring to the preparation method of Example 1, the adipate salt of the fused-ring pyrimidine compound shown in Formula 3 was prepared.
[0122] 1 H-NMR (400MHz, DMSO-d 6 )δ: 9.44(s, 1H), 8.94(s, 1H), 7.75(s, 1H), 7.34(m, 2H), 7.14(d, J=9.6Hz, 1H), 6.98(dd, J=8.0 Hz, J=7.2Hz, 1H), 3.98(m, 1H), 3.74(s, 3H), 3.04(d, J=12.4Hz, 2H), 2.58(dd, J=12.4Hz, J=10.4Hz, 2H), 2.40(s, 3H), 2.17(m, 2H), 1.84(d, J=11.6Hz, 2H), 1.57-1.54(m, 2H), 1.50-1.48(m, 2H) ppm.
Embodiment 3
[0123] Embodiment 3 Preparation of fused ring pyrimidine compound phosphate as shown in formula 4
[0124] Referring to the preparation method of Example 1, the fused ring pyrimidine compound phosphate shown in formula 4 was prepared.
[0125] 1 H-NMR (400MHz, DMSO-d 6 )δ:9.47(s,1H),8.94(s,1H),7.74(s,1H),7.72-7.33(m,2H),7.16(d,J=11.6Hz,1H),6.99(m,1H ),4.13(m,1H),3.74(s,3H),3.22(d,J=12.4Hz,2H),2.83(dd,J=12.4Hz,J=11.6Hz,2H),2.40(s,3H ), 1.86(m,2H), 1.76(m,2H)ppm.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


